Business Context and Reporting Period
Company: National HealthCare Corporation (NHC)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Operations: NHC operates 80 skilled nursing facilities (10,329 beds), 26 assisted living facilities, 9 independent living facilities, 3 behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies across 9 states, primarily in the southeastern U.S.
Key Financial Metrics
| Metric (in thousands) | Q2 2025 | Q2 2024 | 6M 2025 | 6M 2024 |
|---|---|---|---|---|
| Net Operating Revenues | $374,910 | $300,658 | $748,607 | $597,834 |
| Net Income (GAAP) | $24,113 | $27,106 | $56,403 | $53,357 |
| Net Income Attributable to NHC | $23,722 | $26,844 | $55,927 | $53,057 |
| Diluted EPS | $1.52 | $1.73 | $3.59 | $3.42 |
| Operating Cash Flow (6M) | $102,074 | $60,307 | - | - |
| Cash & Equivalents (End of Period) | $110,992 | $136,214 | - | - |
| Total Debt (Long-term + Current) | $110,000 | $137,000 | - | - |
Margins (Q2 2025 vs Q2 2024):
- Operating Margin: 9.1% (vs 7.6%)
- Net Income Margin: 6.4% (vs 9.0%)
- Effective Tax Rate: 25.0% (vs 25.9%)
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 24.7% in Q2 2025 and 25.2% for the six months ended June 30, 2025. This was driven by a 9.6% increase in same-facility revenues and the inclusion of the White Oak acquisition (closed August 2024).
- Profitability: While GAAP net income decreased slightly in Q2 2025 ($23.7M vs $26.8M), Adjusted Net Income (Non-GAAP) increased 64.7% to $25.7M. The GAAP decline was primarily due to a $5.1M unrealized loss on marketable equity securities in Q2 2025, compared to a $9.1M unrealized gain in Q2 2024.
- Cost Management: Agency nurse staffing expenses dropped significantly to $0.98M in Q2 2025 from $4.1M in Q2 2024. Total salaries and wages increased 25.8% year-over-year, largely due to the White Oak acquisition.
- Debt Reduction: The company repaid $27M of its long-term debt during the first six months of 2025, reducing total debt from $137M to $110M.
- Census: Skilled nursing facility occupancy averaged 89.4% in Q2 2025, up from 89.0% in the prior year.
Guidance, Outlook, and Risks
Management Commentary: Management highlights improved operational efficiency, specifically the reduction in agency staffing costs and increased per diem rates from Medicare (up 6.4%) and Medicaid (up 8.3%). The White Oak acquisition is described as accretive to earnings. The company maintains a focus on quality ratings, with 60% of its skilled nursing facilities rated 4 or 5 stars.
Regulatory & Tax Outlook: - Medicare/Medicaid: FY2026 Medicare rates for SNFs are projected to increase by 3.2%. However, home health payments are projected to decrease by 6.4% in FY2026. - Tax Legislation: On July 4, 2025, the "One Big Beautiful Bill Act" (OBBBA) was signed, making key elements of the Tax Cuts and Jobs Act permanent. NHC is evaluating the impact on deferred tax balances.
Risks and Contingencies: - Legal Proceedings: A Qui Tam complaint regarding billing for hospice services (U.S. ex rel. Marshall v. Caris HealthCare, L.P.) remains pending after the government declined to intervene. NHC intends to vigorously defend the matter. - Market Risk: NHC holds significant marketable equity securities ($162.9M), with 70.2% concentrated in National Health Investors (NHI). A 10% change in NHI's stock price would impact fair value by approximately $16.3M. - Liability Reserves: Accrued risk reserves for professional liability and workers' compensation totaled $108.98M as of June 30, 2025.
Investor Verification Checklist
- Non-GAAP Reconciliation: Verify the adjustment for unrealized gains/losses on marketable equity securities, which caused a significant swing in GAAP net income between 2024 and 2025.
- White Oak Integration: Assess the long-term accretion of the White Oak acquisition (15 SNFs, 2 ALFs, 4 ILFs) to earnings and cash flow.
- Concentration Risk: Review the exposure to National Health Investors (NHI) stock, which comprises over 70% of the equity portfolio.
- Regulatory Impact: Monitor the impact of the proposed 6.4% decrease in FY2026 Medicare home health payments on the Homecare and Hospice segment.
- Legal Exposure: Track the status of the Qui Tam complaint regarding Caris Healthcare billing practices.
- Debt Covenants: Confirm continued compliance with financial covenants on the $200M credit facility following the recent debt paydown.